Reverse transcriptase inhibitors, nucleotidal

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

NtRTIs; Nucleotide analogues

Definition
This section has been translated automatically.

Artificial, chemical compounds that interfere with the structure of nucleic acids (RNA and DNA) by inhibiting reverse transcriptase. They directly block the enzyme by attaching themselves, thereby rendering the tool that assembles the genetic information inoperable.

Pharmacodynamics (Effect)
This section has been translated automatically.

After conversion into a triphosphate, NtRTI act as an inhibitor of reverse transcriptase due to their structural similarity to the physiological substrate deoxyadenosine triphosphate. After incorporation into the DNA, they cause a chain termination, so that the viral genes can no longer be expressed. However, this process does not lead to eradication of the viral genome.

Indication
This section has been translated automatically.

Various nucleotide analogues are approved for the treatment of HIV infection (see tenofovir below), cytomegaly (see cidofovir below) and hepatitis B (see adefovir below).

Incoming links (2)

Adefovir; Virustatics;

Authors

Last updated on: 29.10.2020